Therapeutic Effects of Heart Failure Medical Therapies on Standardized Kidney Outcomes: Comprehensive Individual Participant–Level Analysis of 6 Randomized Clinical Trials

When applying standardized stringent kidney end point definitions, steroidal mineralocorticoid receptor antagonists, angiotensin receptor-neprilysin inhibitor, and SGLT2 inhibitors have either neutral or beneficial effects on kidney outcomes in heart failure. Applying less stringent definitions increased event rates but included acute declines in eGFR that might not ultimately reflect long-term effects on kidney disease progression.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2024-09-01
DOI
https://doi.org/10.1161/circulationaha.124.071110
Citations
13
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
5.23
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Therapeutic Effects of Heart Failure Medical Therapies on Standardized Kidney Outcomes: Comprehensive Individual Participant–Level Analysis of 6 Randomized Clinical Trials

Brian Lee Claggett, Brendon Lange Neuen, Pardeep S. Jhund, John J.V. McMurray et al.
13 citations
Circulation
Heart Failure Treatment and Management
5.23
article

Therapeutic Effects of Heart Failure Medical Therapies on Standardized Kidney Outcomes: Comprehensive Individual Participant–Level Analysis of 6 Randomized Clinical Trials

Brian Lee Claggett, Brendon Lange Neuen, Pardeep S. Jhund, John J.V. McMurray, Marc A. Pfeffer, Finnian R. McCausland, Jawad H. Butt, Faiez M. Zannad, Iris E. Beldhuis, Milton Packer, Scott David Solomon, Muthiah Vaduganathan, Carolyn S.P. Lam, Adriaan A. Voors, Akshay S. Desai, Bertram Pitt, Hiddo J.L. Heerspink
article en
13 citations

Abstract

When applying standardized stringent kidney end point definitions, steroidal mineralocorticoid receptor antagonists, angiotensin receptor-neprilysin inhibitor, and SGLT2 inhibitors have either neutral or beneficial effects on kidney outcomes in heart failure. Applying less stringent definitions increased event rates but included acute declines in eGFR that might not ultimately reflect long-term effects on kidney disease progression.

CirculationVol. 150(23)
Brigham and Women's Hospital (US), University Medical Center Groningen (NL), Inserm (FR), University of Groningen (NL), University of Michigan (US), Baylor University Medical Center (US), Copenhagen University Hospital (DK), Rigshospitalet (DK), UNSW Sydney (AU), British Heart Foundation (GB), Zealand University Hospital (DK), Centre Hospitalier Régional et Universitaire de Nancy (FR), National University Heart Centre Singapore (SG), The George Institute for Global Health (AU), Université Bourgogne Franche-Comté (FR), Duke-NUS Medical School (SG), National Heart Centre Singapore (SG), French Clinical Research Infrastructure Network (FR), University of Glasgow (GB), Université de Lorraine (FR)
Good health and well-being
Openalex Percentile: Top 4%
Heart Failure Treatment and Management
5.23
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.